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Abstract
MICROBIAL EVALUATION OF THE CALAMUS™ HEATED GUTTAPERCHA DELIVERY SYSTEM
By Christopher J. Smart, DDS
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Dentistry at Virginia Commonwealth University.
Virginia Commonwealth University, 2013.
Director: Karan J. Replogle, DDS, MS
Program Director, Department of Endodontics

If gutta-percha cartridges are contaminated with bacteria prior to obturation then contamination
of the root canal system may result. Successful treatment not only depends on bacterial
elimination but also depends on prevention of recontamination. This study was motivated by the
observation that endodontists frequently use single use gutta-percha cartridges on multiple
patients. The goal of this study was to determine if cross contamination occurred when a single
gutta-percha cartridge in the Calamus™ Flow System was used on multiple patients.

An

effective recovery method was established during a pilot study using Enterococcus faecalis as a
sample bacterium. Microbial recovery was obtained using standard media. The Calamus™
heated gutta-percha delivery system was evaluated to determine the percentage of cartridges with
recoverable microorganism under four conditions. Results showed that for cartridges tested
immediately after removal from manufacturer’s packaging, the observed negative outcome was
0/10 (0%). For cartridges used on a single patient with an alcohol wipe after use, the negative

outcome was 0/20 (0%). For cartridges used on a single patient with no alcohol wipe after use,
the negative outcome was 1/20 (5%). For cartridges used on three patients with an alcohol wipe
after each use, the number of observed negative outcomes was 0/20 (0%). Using 95% score
confidence intervals, the results indicate that the percentage of cartridges with recoverable
microorganism under the four conditions is below 27.8% for cartridges sampled from
manufacturer’s packaging, 16.1% for cartridges used on a single patient with a alcohol wipe after
use, 23.6% for cartridges used on a single patient with no alcohol wipe after use, and 16.1% for
cartridges used on three patients with an alcohol wipe after each use. Evidence from this study
indicates using Calamus™ flow cartridges on multiple patients vs. single patient does not lead to
an increased contamination risk.

Introduction

The goal of root canal treatment is to eradicate microbiota infecting the root canal system
creating a sterile environment and to obturate with a 3-D obturation that seals the canal from
reinfection. Due to the complex anatomy of the root canal system this is difficult with current
instruments and techniques. Bacterial elimination is accomplished by mechanical
instrumentation techniques using hand and rotary files in combination with various chemical
irrigants, interappointment medicaments, and obturation materials. Maintaining the chain of
asepsis is extremely important to prevent bacterial contamination of the root canal system.
Based on current infection control concepts, the instruments and materials used during
endodontic treatment (including gutta-percha delivery systems) must be as bacteria-free as
possible.
Role of Bacteria
Since the first discovery of oral bacteria or “animalcules” in the late 1600’s, dentistry has
made extensive progress in treating dental diseases (1). Miller (1894) discovered that bacteria
could infect and persist in the pulpal tissues causing pulpal disease (2). This study helped
change the way dentists looked at bacterial involvement with pulpal symptoms and pulpal
disease in patients.
Kakehashi, et al. conducted a landmark study using an animal model involving one group
of germ-free rats in which pulpal exposure was induced and a second group of standard germpresent rats in which pulpal exposure was induced. The germ-free rats with orally exposed

pulpal tissue and periapical tissues showed no signs of apical periodontitis, while standard rats
showed signs of pulpal necrosis and apical periodontitis (3).
In a subsequent study, Sundqvist, showed that traumatized incisors with clinically intact
crowns and necrotic pulp remained normal and that only the teeth that harbored bacteria
developed apical periodontitis (4). Moller et al. showed that aseptically devitalized sealed teeth
remained disease-free after a period of 6-7 months. However, teeth that were infected by oral
flora developed apical periodontitis (5). These three studies by Kakehashi, Sundqvist, and
Moller were the foundation of and furthered understanding of the bacterial etiology of periapical
disease.
Later studies showed the effect of bacteria on the outcome of endodontic treatment. In a
clinical study of 55 root canals, Sjogren et al. demonstrated that having a bacteria-free canal
before obturation positively affected the success of endodontic treatment. Ninety four percent of
cases that yielded a negative culture were healed at five years’ recall. However, in cases that
yielded positive samples prior to obturation, the success rate of treatment was only 68%. This
study emphasized the importance of sterilization of the root canal for optimal outcome (6).
Microbiology of Endodontics
When the pulp succumbs to necrosis, bacteria begin to colonize it immediately.
Facultative anaerobes dominate the initial stages of necrosis, but as necrosis progresses, obligate
anaerobes take over (7). Major factors affecting bacteria in the necrotic pulp include oxygen
tension, type and availability of nutrients, as well as bacterial interactions. Low oxygen tension
is a result of the bacteria consuming the oxygen and the loss of blood supply to the pulp (8-10).
Saccharolytic bacterial species dominate initially. These species metabolize products of
the pulp, proteins and other components of saliva and metabolic byproducts of other bacteria. As
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the infection matures, asaccharolytic bacterial species dominate as the infection progresses
metabolizing proteins into amino acids (11).
The specific bacteria most commonly isolated from primary endodontic infections
include Fusobacterium, Streptococcus, Porphyromonas, Prevotella, Eubacterium,
Peptostreptoccus, Propionibacterium and Campylobacter species (12). Classic studies have
shown that black pigmented rods are more likely to be associated with clinical symptoms such as
pain and swelling (13, 14).
Bacteria harboring in root canals can either be in a planktonic form, biofilm form, or both
(15). Planktonic microbiota have been shown to be easily eradicated by different methods,
whereas biofilm microbiota have been shown to be resistant. Biofilms are communities of
organisms attached to root canal walls that consist of an extracellular polysaccharide matrix
which helps protect bacteria from the harsh environment, allows for metabolic commensalism
among different species, and aids resistance to antimicrobial agents (16-19).
Completely removing bacterial biofilms from the root canal system is difficult and could
be one reason why apical periodontitis appears in secondary infections. Bacteria that are often
associated with treatment failures are different from the bacteria in primary infections.
Secondary infections contain fewer bacteria species and are dominated by gram-positive
facultative anaerobes including Streptococci, Lactobacilli, Propionibacterium species, yeasts,
Enterococcus faecalis and Actinomyces species (20-23). E. faecalis is one of the most frequently
isolated bacteria from failing previously treated teeth.
Enterococcus faecalis
E. faecalis is a gram-positive facultative anaerobic coccus which is a normal inhabitant of
human intestinal flora. It can cause life-threatening infections in humans, especially in the
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nosocomial environment, where the naturally high levels of antibiotic resistance found in E.
faecalis contributes to its pathogenicity (24).
Clinical studies have shown that E.faecalis has been isolated from oral cavity and
gingival sulcus and can be present in untreated root canals with primary infections (25-28).
However, it has been most commonly isolated from root canal-treated teeth with apical
periodontitis. Several studies revealed that E. faecalis is the most frequent species isolated with
prevalence values reaching up to 90% of cases in teeth with apical periodontitis (19, 20, 24, 27).
It has also been estimated that root canal-treated teeth are nine times more likely to harbor E.
faecalis than primary infections (19). It is a fastidious organism that is thought to invade root
canals during treatment from the oral fluids and then persists due to its ability to adapt to
ecological conditions and survive (30).
E. faecalis has been shown to be resistant to high pH calcium hydroxide (31, 32). This
resistance seems to be related to its internal functional proton pump that acidifies the cell
cytoplasm (33). The ability of E. faecalis to penetrate deep into dentinal tubules to escape from
chemomechanical preparation and intracanal medicaments is another survival mechanism (34).
E. faecalis is capable of entering a viable but non-cultivable (VBNC) state. This survival
mechanism is utilized by other bacteria as well as E. faecalis when exposed to environmental
stress (35, 36). In the VBNC state, bacteria are able to survive periods of starvation and then
resume their growth when nutrients become available again (30). E. faecalis has been shown to
survive starvation in root canal-treated teeth providing a nidus for subsequent infection (37).
E. faecalis has also demonstrated that it can form coaggregates with other bacterial species
resulting in biofilms (38). The presence of E. faecalis in the root canal system, its fastidious
survival mechanisms, and its association with secondary infections make it essential that the
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antimicrobial measures taken before obturation be as effective as possible against this
microorganism.
Gutta-Percha
The success of treatment not only depends on bacterial elimination but also depends on
the prevention of recontamination after cleaning and shaping the root canal system. Therefore,
obturation should not introduce additional irritants into the root canal system that could
ultimately decrease successful treatment outcomes.
Material used for obturation of root canals has changed as the field of endodontics has
evolved. Obturating materials have included both pastes and solid materials such as silver cones.
Gutta-percha, carrier-based gutta-percha, and Resilon are the materials that are primarily used
today, with gutta-percha being the most commonly used obturation material.
Gutta-percha fulfills most of the ideal characteristics originally outlined by Grossman
(1940). The ideal characteristics of an obturating material are: 1) easily introduced into the root
canal, 2) seals the canal laterally as well as apically, 3) does not shrink after being inserted, 4)
is impervious to moisture, 5) is bacteriostatic or at least does not encourage bacterial growth, 6)
is radiopaque, 7) does not stain tooth structure, 8) does not irritate periradicular tissues, 9) is
sterile, or easily and quickly sterilized, immediately before the insertion, and 10) is removed
easily from the root canal, if necessary (39).
Gutta-percha (Palaquium) is a genus of tropical trees native to Southeast Asia and
northern Australasia. The milky exudate from the trees is evaporated and the resulting material
is called gutta-percha. Chemically, gutta-percha is a polyterpene, a polymer of isoprene, or
polyisoprene, specifically the trans-1,4-polyisoprene (40). It is the dominant isomer in both
gutta-percha and balata.
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Gutta-percha was introduced as a root canal filling material in 1847 by Hill who
developed the material and called it “Hill’s-stopping”. It was composed of a mixture of bleached
gutta-percha and carbonate of lime and quartz (40). Bowman (1867) was the first to use guttapercha for a root canal filling on an extracted molar (40). Later Perry (1883) used pointed gold
wire wrapped with soft gutta-percha which he rolled and packed into the canal (40).
The first commercial manufacture of gutta-percha points was by S.S White Company in
1887 (40). A newer mixture of gutta-percha was introduced by Rollins in 1893. He added pure
oxide of mercury to the gutta-percha. This product was removed later due to dangerous levels of
mercury (40). In 1914 Callahan introduced softening and dissolution of gutta-percha with the
use of rosins in obturation (40). In 1959 Ingle and Levine were the first to propose
standardization of root canal instruments and filling materials. Standardized gutta-percha was
introduced to the profession in 1959 (41).
Gutta-percha exists in two crystalline forms α and β. The mechanical properties of the α
and β forms are the same except when heated. Heating gutta-percha results in volumetric
difference (42, 43, 44). When in β form, gutta-percha is compactable. When heated, it changes
to α phase and becomes pliable and therefore, can be made to flow. When α phase gutta-percha
cools normally, it crystallizes to the β form with a slight shrinkage of between 1 and 2% (45).
Gutta-percha has both advantages and disadvantages. Shrinkage is one disadvantage.
Another is its inability to bond to dentin. The major advantages of gutta-percha are its plasticity,
ease of manipulation, minimal toxicity, radiopacity, and ease of removal with heat or solvents
(44). Gutta-percha cones consist of approximately 20% gutta-percha, 65% zinc oxide, 10%
radiopacifiers, and 5% plasticizers (46). These chemical additives alter the material behavior
compared to pure gutta-percha (47).
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Obturation Methods
There is very little scientific evidence to support one method of obturation versus another
in terms of outcomes of success or failure. Lateral compaction, warm vertical compaction,
continuous wave compaction, warm lateral compaction and carrier based compaction are the
methods available.
Currently there are multiple thermoplasticized injectable gutta-percha obturating systems
used today. The concept of obturating root canals using thermoplasticized injectible guttapercha was introduced by Ye et al (48). Thermoplascticized injectible gutta-percha may be used
as a primary technique or, as it is used most often today, as a back-filling technique to obturate
the remaining canal space after initial compaction technique.
Thermoplasticized injectable gutta-percha obturating systems include pellet based units
and cartridge based units. The Obtura (Obtura Spartan, Earth City, MO) and HotShot (Discus
Dental, Culver City, CA) use gutta-percha pellets. These units require gutta-percha pellets to be
inserted into the delivery system gun, and then the gutta-percha pellet is heated to 150o to 200oC
prior to injection into the canal. The Calamus (DENTSPLY Tulsa Dental Specialties, Tulsa,
OK), Elements (SybronEndo, Orange, CA), and Ultrafill 3D (Coltene/Whaledent, Cuyahoga
Falls, OH) use gutta-percha cartridges which are inserted into the system. The Ultrafill™ system
is a low heat system that heats preloaded gutta-percha cartridges from 70o to 90oC prior to
injection into the canal. The Elements™ and Calamus™ systems heat preloaded gutta-percha
cartridges from 60o to 200oC prior to injection into the canal. These systems have been
developed with minimal guidelines for clinical asepsis. The only scientific evidence available
for these units comes from studies completed on the Obtura™ and the Ultrafill™ systems (49,
50). The focus of the present study is based on the Calamus™ system.
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The Calamus™ unit cartridges come in manufacturing packages that give no information
on how the product is prepared. The Calamus™ directions outline the use for cartridges and are
as follows:
1. Cartridges are for single patient use.
2. Prior to using a cartridge on a patient, wipe the cartridge tip with alcohol or a
disinfectant.
3. Store cartridges at room temperature.
4. Do not immerse the cartridges into any liquid.
5. Do not use cartridges after the expiration date.
6. Cartridges CANNOT be re-heated and/or re-used.
Clinicians can assume that if the gutta-percha pellets or cartridges are contaminated with
bacteria prior to obturation the contamination of the root canal system may result. Furthermore,
some clinicians may use these pellets and single use cartridges on multiple patients resulting in
cross-contamination. The success of treatment not only depends on bacterial elimination but also
depends on the prevention of recontamination after cleaning and shaping the root canal system.
Therefore, obturation should not introduce additional irritants into the root canal system that
could ultimately decrease successful treatment outcomes.
This study was motivated by the observation that endodontists frequently use single use
gutta-percha cartridges on multiple patients. The goal of this study was to determine if cross
contamination occurred when a single gutta-percha cartridge in the Calamus™ Flow System was
used on multiple patients.
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Materials and Methods

All non-surgical root canal treatment (NSRCT) (vital and necrotic) or non-surgical
retreatment cases treated in the VCU School of Dentistry Graduate Endodontic Practice are
obturated using warm continuous wave obturation which utilizes thermoplasticized gutta-percha
cartridges or pellets. Each cartridge contains enough gutta-percha to obturate 2-4 cases. These
cartridges are discarded after use. All cases are treated using a standard protocol for cleaning
and shaping, irrigation and obturation. This study included cases treated during Spring Semester
2012.
The gutta-percha cartridges used on patients that presented for NSRCT at VCU School of
Dentistry were evaluated after continuous wave obturation for the existence of microorganisms
under four conditions:
1. 10 cartridges immediately removed from manufacturer’s packaging,
2. 20 cartridges used on single patients cleaned with an alcohol wipe after use,
3. 20 cartridges used on single patients with no alcohol wipe after use,
4. 20 cartridges (1 cartridge used per 3 patients) with an alcohol wipe after each use.
All materials and methods were under the control of one operator. The media used for
recovery of microorganisms was sterile saline and the media used for growth of microorganisms
included brain-heart infusion broth (BHIB) and brain-heart infusion agar (BHI agar) plates.
BHIB and BHI agar are highly nutritious general-purpose growth media used for culturing
fastidious and nonfastidious microorganisms. One Calamus™ Dual unit was used throughout
the study (Fig. 1). Calamus™ cartridges from only unopened manufacturer’s storage packages
-9-

were used in this study. The Calamus™ gutta-percha cartridge is an aluminum prefilled capsule
that contains gutta-percha with a silver cartridge tip (Fig. 2).
Pilot Study Sample Preparation
The pilot study sample preparation is shown in Figure 3. Cartridges used to evaluate the
recovery method used were inoculated with an overnight culture of E. faecalis. An overnight
stock culture of E.faecalis was prepared by thawing the culture in the biological safety cabinet
and pipetting a10 ul aliquot of E.faecalis into 5 ml of BHI broth. The culture was incubated at
37oC for 24hrs. The cartridges were prepared by removing them from packaging with sterile
forceps and gloves, wiped with a 2x2 alcohol wipe, allowed to dry in the biological safety
cabinet, and pre-weighed on a sterile laboratory scale. Next, all tips were inoculated by the same
protocol by inserting the tip of the cartridge to the hub in the overnight culture with sterile
forceps and holding it there for 10 seconds. Tips were then removed in the biological safety
cabinet, dried, and reweighed.
After drying, tips were treated in three ways. One tip was placed into a tube containing 3
ml of sterile saline with forceps and allowed to incubate at room temperature for 24hrs. The
second tip was placed into another tube containing 3ml of sterile saline with forceps and was
vortexed in preparation for immediate recovery. The third tip was held with sterile forceps and
swabbed with a sterile cotton swab soaked in sterile saline. The swab was then inserted and
twirled into a tube containing 3ml of sterile saline. This 3 ml volume was sufficient to cover the
entire silver cartridge tip but only partially cover the aluminum cartridge of the gutta-percha.
Tubes were labeled according to how the sample was treated.
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Figure 3. Pilot Study Sample Preparation and Recovery Method
Preparation of Manufacturer’s and Patient Samples
The preparation of manufacturer’s and patient samples is given in Figure 4. In all patient
cases in this study, hand and rotary instrumentation in combination with antimicrobial solutions
of 5.25% sodium hypochlorite (NaOCl) and 17% etheylenediamine tetraacetic Acid (EDTA)
were used prior to obturation. If a case was non-vital, 2% chlorhexidine (CHX) was added as an
antimicrobial irrigant. If the case was a non-surgical retreatment the addition of chloroform was
used prior to obturation. In multiple visit cases calcium hydroxide (Ca (OH)2) was used as an
intracanal intraappointment medicament prior to obturation.
Preparation of new samples prior to use followed manufacturer’s instructions and utilized
the following protocol. Cartridges were removed with sterile forceps and gloves, wiped with a
2x2 alcohol wipe, and placed into the flow hand piece prior to patient usage. After cleaning and
shaping procedures were completed, master cones were fitted and down packed with the pack
- 11 -

hand piece. When down packing was completed the Calamus™ flow hand piece with the
inserted cartridge was used to backfill the canals. After the last usage of the flow hand piece the
cartridge tip was treated in two ways, it was wiped with a 2x2 alcohol wipe or was not wiped.
After the patient was dismissed from the operatory, the cartridge was removed from the flow
hand piece with sterile gloves and forceps and placed into a test tube containing 3 ml of sterile
saline and labeled according to how it was treated (alcohol wipe or no alcohol wipe).
Preparation of the samples for multiple cases on patients followed single patient
procedures with minor differences. After each case was obturated and before its next use, the
cartridge tip was wiped with a 2x2 alcohol wipe. After the final usage the cartridge tip was
placed aseptically into a 3ml of sterile saline.

Figure 4. Patient and Manufacturer’s Sample Preparation
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Pilot Study Recovery Method
The recovery method used in the pilot study is shown in Figure 3. A standard Drop
Plating method on BHI plates was used to evaluate the number of bacteria from the overnight
cultures and the number of bacteria recovered from Calamus™ cartridge tip samples.
Overnight culture determination was done according to the following protocol. A 10 ul
aliquot of overnight culture was pipetted into a centrifuge tube containing 990ul of BHI broth
labeled tube L and vortexed. From tube L, a 100 ul aliquot was pipetted into another tube
containing 900 ul of BHI broth labeled M and vortexed. From tube M, a 250 ul aliquot was
pipetted into another tube containing 750 ul of BHI broth labeled N and vortexed. Dilutions
were carried out in tubes labeled O, P, Q, and R using the same method as from tube M to tube
O. Twenty ul aliquots from tubes M through R were drop plated in triplicate onto BHI plates.
All plating was done in duplicate. The two Calumus™ tip samples and the sterile cotton swab
sample followed the same protocol but differed in the fact that one of the Calamus™ tip sample
was treated 24hrs later to mirror patient treatment. A 20 ul aliquot was taken directly from the
sample drop plated on the BHI plate. A 250 ul aliquot was pipetted into a centrifuge tube
containing 750 ul of BHI broth labeled B and vortexed. From tube B, a 250 ul aliquot was
pipetted into another tube containing 750 ul of BHI broth labeled C and vortexed. Dilutions
were carried out in tubes labeled D, E, and F using the same method as from tube B to tube C.
The 20 ul aliquots from tubes B through C were drop plated into triplicate onto BHI plates (Fig.
4). All plating was done in duplicate.
Patient and Manufacturer’s Samples Recovery Method
The patient and manufacturer’s samples recovery method is shown in Figure 4. All test
tube samples from patient usage and manufacturer’s packaging were labeled accordingly. The
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samples remained at room temperature for 24-48hrs. After 24-48hrs samples were taken to a
microbiology lab for sampling in a biological safety cabinet. The following protocol was
utilized for all samples after remaining at room temperature for 24-48hrs:
1.

Samples containing the cartridges were vortexed for 30 seconds to free any adhering
microorganisms from exposed surfaces.

2.

Two 250 ul aliquots from the sample were directly plated and streaked onto two
separate BHI agar plates labeled anaerobic culturing.

3. Two 250 ul aliquots from the sample were directly plated and streaked onto two
separate BHI agar plates labeled aerobic culturing.
4. Two 250 ul aliquots from the sample were pipetted into two test tubes containing 9.0
ml of BHIB labeled anaerobic culturing and were vortexed.
5. Two 250 ul aliquots from the sample were pipetted into two test tubes containing 9.0
ml of BHIB labeled aerobic culturing and were vortexed.
6. The BHI agar plates and BHIB test tubes were placed in two separate jars labeled
aerobic or anaerobic of the Anoxomat system. The Anoxomat system is a system for
culturing anaerobes and micro-aerobes in any laboratory, clinical or industrial setting.
It is a complete and unique system creating rapidly and automatically anaerobic,
micro-aerophilic or capnophilic conditions in an anaerobic jar. The anaerobic jar
conditions included 80% N2, 10% CO2, 10% H2, and 0 % O2. The aerobic jar
conditions included 80% N2, 10% CO2, 10% H2, and 6 % O2.
7. When the jars completed their cycles to create this environment they were then
incubated at 37oC for 24-48 hrs.
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8. After 24-48hrs BHI agar plates and BHIB test tubes were visually evaluated for the
presence of microorganisms. If colonies were not visualized on the BHI agar plates
or the BHIB test tube was not turbid then the samples were considered negative. If
colonies were visualized on the BHI agar plates or the BHIB test tube appeared turbid
then the samples were considered positive.
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Results
An effective recovery method for E. faecalis inoculated gutta-percha cartridges was
established during a pilot study. This method effectively recovered inoculated bacteria from the
cartridge tips allowing the use of this method on patient samples. Figure 5 shows that tips
sampled after 24 hours resulted in the highest recovery of bacteria at 4.97% followed by tips
tested immediately at 4.52%. The cotton swabs recovered the lowest amount of bacteria at
3.19%.

Figure 5. Pilot Study Percent Recovery Graph
Following the pilot recovery studies, gutta-percha cartridges used in the Calamus™ Flow
Gutta-Percha Delivery System were evaluated to determine if cross contamination occurred
when a single use gutta-percha cartridge was used on multiple patients. Gutta-percha cartridges
observed negative outcomes were determined under four conditions:
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1. 10 cartridges immediately removed from manufactures packaging,
2. 20 cartridges used on single patients cleaned with an alcohol wipe after use,
3. 20 cartridges used on single patients with no alcohol wipe after use,
4. 20 cartridges (1 cartridge used per 3 patients) with an alcohol wipe after each use.
The observed negative outcome was 0/10 (0%) for cartridges tested immediately after
removal from manufacturer’s packaging. The observed negative outcome for cartridges used on
a single patient cleaned with an alcohol wipe after use was 0/20 (0%). The observed negative
outcome for cartridges used on a single patient with no alcohol wipe after use was 1/20 (5%).
The observed negative outcome for cartridges used on three patients (60 patients) with an alcohol
wipe after each use was 0/20 (0%).
Using 95% score confidence intervals, results from Figure 6 indicates that the percentage of
cartridges with recoverable microorganism under the four conditions is below 27.8% for
cartridges taken directly out of manufacturer’s packaging, 16.1% for cartridges used on a single
patient cleaned with an alcohol wipe, 23.6% for cartridges used on a single patient with no
alcohol wipe, and 16.1% for cartridges used on three patients with an alcohol wipe after each
use.

- 17 -

Figure 6: 95% Confidence Intervals of Observed Negative Cartridges

Discussion

As stated earlier, Calamus™ gutta-percha cartridges are marketed as single use to prevent
cross contamination between patients. This study was motivated by the observation that
endodontists frequently use these single use gutta-percha cartridges on multiple patients. The
purpose of this study was to determine if cross contamination occurred when a single guttapercha cartridge in the Calamus™ Flow System was used on multiple patients.
Microbial recovery from cartridges among patient samples in this study was all negative for
99 out of 100 patients (60 total cartridges). The high number of negative cultures may be due to
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the effects of mechanical instrumentation techniques in combination with various chemical
irrigants and interappointment medicaments prior to obturation. Furthermore, the temperature
(170oC) of the obturation unit may have been lethal to remaining bacteria on or in the cartridge
tip prior to use (49).
Prior to this study there has only been one study that completed microbiological
evaluation of high heat gutta-percha delivery systems. Winford et al. tested the Unitek Obtura™
heated gutta-percha system to determine whether microorganisms have the ability to survive
passage through the mechanism or to survive on the applicator tip of the instrument during
clinical use. No organisms tested survived the passage through the heated chamber or were
demonstrable on the applicator tip during clinical usage patterns. The authors suggest that the
use of NaOCl, the temperature of the applicator tip, and alcohol wiping the tip as being sufficient
to control the microflora tested (50). Their results are similar to the findings in this study. The
use of 5.25% NaOCl, 17% EDTA, 2% CHX, Ca (OH)2, multiple alcohol wipes, and the 170oC
temperature of the Calamus™ unit may also have contributed to the lack of positive cultures.
When looking at the results of this study it appears that a clinician may have a higher risk
of obtaining a positive culture when using a new cartridge out of manufacturer’s packaging
versus using a used one on multiple cases (27.8% for cartridges out of manufacturer’s packaging
and 16.1% for cartridges used on multiple patients). The results appear this way because only 10
new cartridges were sampled resulting in a smaller sample size compared to the number of cases
sampled (20). One can assume if a higher sample size was used then the confidence intervals
would have decreased thus making the risk of a positive culture equal to or below that of cases
treated with alcohol wipes.
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In conclusion, evidence from this study indicates using a single use Calamus™ cartridge
on multiple patients versus one patient does not lead to an increased cross-contamination risk.
Prior to adopting the use of single use patient cartridges on multiple cases as a standard of care
the use of a single gutta-percha cartridge for multiple patients requires additional microbial
studies to evaluate the Calamus™ flow gutta-percha cartridges under different clinical
conditions.
Study variables need to be controlled for case type, i.e. vital, non-vital, and retreatment.
Sample size needs to be increased for all case types. Increasing the sample size would have
likely decreased the risk of obtaining positive cultures. Statistical analysis across and among
case type should be completed.
The use of a single researcher added bias to the study. Any future studies should attempt
to remove this bias by adding more researchers.
The use of a different culturable microorganism, the use of different growth media, and
the utilization of more robust identification methods such as polymerase chain reaction methods
might more reliably allow for prediction of cross-contamination.
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Appendix

Figure 1. Calamus Unit

Figure 2. Cartridge
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Table 1. Percent Recovery of Pilot Study
Tips after 24hr

Tips Immediately

Cotton swabs immediately

0.026
0.059
0.038
0.059
0.037
0.14
0.03
0.059
0.035
0.085
0.049799513

0.026
0.081
0.11
0.085
0.02
0.02
0.012
0.15
0.023
0.11
0.045234761

0.0077
0.009
0.059
0.11
0.05
0.02
0.057
0.03
0.11
0.013
0.031925007

4.97%

4.52%

3.19%

Table 2. Raw Data of Observed Negative Outcomes
Raw Data Collection of Observed Negative Outcomes
Singe use with alcohol
Single use with no
Multiple use with
wipe
alcohol wipe
alcohol wipe
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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Package Samples
0
0
0
0
0
0
0
0
0
0
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